West Pharmaceutical Services, Inc.
WST
$230.11
$6.382.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 484.60M | 490.90M | 446.20M | 601.80M | 853.90M |
| Total Receivables | 575.80M | 566.60M | 502.00M | 543.90M | 533.50M |
| Inventory | 377.00M | 401.20M | 419.20M | 429.90M | 434.70M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 100.70M | 91.90M | 115.60M | 117.30M | 114.30M |
| Total Current Assets | 1.54B | 1.55B | 1.48B | 1.69B | 1.94B |
|
|
|||||
| Total Current Assets | 1.54B | 1.55B | 1.48B | 1.69B | 1.94B |
| Net Property, Plant & Equipment | 1.72B | 1.71B | 1.64B | 1.55B | 1.51B |
| Long-term Investments | 106.00M | 108.80M | 107.30M | 107.60M | 108.50M |
| Goodwill | 106.00M | 108.80M | 107.30M | 107.60M | 108.50M |
| Total Other Intangibles | 10.80M | 12.30M | 12.90M | 13.90M | 15.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 70.60M | 75.00M | 53.00M | 40.00M | 47.00M |
| Total Assets | 3.64B | 3.68B | 3.49B | 3.60B | 3.83B |
|
|
|||||
| Total Accounts Payable | 239.30M | 224.30M | 211.70M | 240.10M | 242.40M |
| Total Accrued Expenses | 138.00M | 79.60M | 82.90M | 66.50M | 161.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.80M | 20.80M | 154.10M | 151.40M | 151.70M |
| Total Finance Division Other Current Liabilities | 154.30M | 191.80M | 185.00M | 190.40M | 116.40M |
| Total Other Current Liabilities | 154.30M | 191.80M | 185.00M | 190.40M | 116.40M |
| Total Current Liabilities | 550.40M | 516.50M | 633.70M | 648.40M | 671.80M |
|
|
|||||
| Total Current Liabilities | 550.40M | 516.50M | 633.70M | 648.40M | 671.80M |
| Long-Term Debt | 202.60M | 202.60M | 72.90M | 72.80M | 72.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 83.90M | 84.50M | 87.00M | 82.40M | 84.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 124.20M | 119.40M | 119.00M | 118.10M | 119.40M |
| Total Liabilities | 961.10M | 923.00M | 912.60M | 921.70M | 948.50M |
|
|
|||||
| Common Stock & APIC | 40.90M | 42.10M | 52.30M | 74.00M | 139.00M |
| Retained Earnings | 3.96B | 3.86B | 3.72B | 3.62B | 3.52B |
| Treasury Stock & Other | -1.32B | -1.15B | -1.20B | -1.02B | -781.40M |
| Total Common Equity | 2.68B | 2.75B | 2.58B | 2.68B | 2.88B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.68B | 2.75B | 2.58B | 2.68B | 2.88B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.68B | 2.75B | 2.58B | 2.68B | 2.88B |
|
|
|||||
